| |
| Magyar Belgyógyász Társaság |
|
| A Magyar Belgyógyász Társaság 49. Nagygyűlése |
 Rendezvény kezdete: 2023.11.16. | Rendezvény vége: 2023.11.18. |
| Helyszín: Visegrád, Thermál Hotel |
Tisztelt Tagtársak!
Közeledik a hazai belgyógyászat legfontosabb eseménye, a 2023. évi Belgyógyász Nagygyűlés, melynek programját mellékelten találhatják.
2023. november 16-18. között új helyszínen, a Visegrádi Thermal Hotelben kerül megrendezésre a Nagygyűlés, melynek nem csak a helyszíne, de a struktúrája is megváltozott.
Kiemelt témánkon „Hormonok belgyógyászati hatásai a klasszikus endokrinológián” túl a három nap alatt a belgyógyászat öt kiemelt ágának a legfontosabb a gyakorlatot érintő újdonságaival ismerkedhetünk meg, egy-egy órás blokk keretében. Tudományos újdonságok bemutatása mellett a Nagygyűlés legfontosabb célja, hogy fórumot teremtsen a hazai belgyógyászat képviselőinek a problémák megbeszélésére és az új kutatási eredmények bemutatására. Ezért rendkívül fontos, hogy a Nagygyűlésen lehetőleg minden magyarországi belgyógyászati műhely képviseltesse magát jelenlétével.
Online regisztráció
Végleges program
Előadások poszter összefoglalói
Névmutató az előadások összefoglalóihoz
A személyes találkozás lehetőségében bízva, várunk minden magyar belgyógyászt november 16-án Visegrádon!
Tisztelettel:
Prof. Dr. Takács István
Magyar Belgyógyász Társaság elnöke |
|
|
 |
| |
| Magyar Immunológiai Társaság |
|
| 46th Annual Meeting of the German Society for Immunology (DGfI) (Hamburg, Germany, 27–30 September 2016) |
| Rendezvény kezdete: 2016.09.27. | Rendezvény vége: 2016.09.30. |
| Szakterület(ek): Allergológia, klinikai immunológia |
| Helyszín: Germany, Hamburg, |
| A rendezvény Web oldala: http://www.immunology-conference.de |
Dear Sir or Madam, Dear colleague,
On behalf of the board of the German Society for Immunology (DGfI), we are delighted to invite you to participate in the 46th Annual Meeting of the German Society for Immunology to be held in Hamburg, Germany from 27–30 September 2016.
Deadline for abstract submission ends on 23 May 2016!
The conference will address the following topics:
• B Cell Activation and Maturation in Germinal Centers
• B Cell Development and Homeostasis
• CD4+ T Cell Subsets
• CD8+ T Cell Differentiation and Responses
• Clinical Immunology
• Dendritic Cells and Macrophages Fetomaternal Immunity
• Immune Cell Memory
• Immune Regulation
• Immune Therapy of Tumors
• Infection Immunology I: Human System
• Infection Immunology II: Model Systems
• Infection Immunology III: Sensing of and Response to Pathogens
• Infection Immunology IV: Metabolism and Micromilieu in Infection
• Lymphocyte Signal Transduction
• Mast Cells and Granulocytes
• Mucosal Immunity
• Natural Killer (NK) and Innate Lymphoid Cells (ILC)
• Neuro-Immune Interactions in Health and Disease
• Novel Aspects in Vaccination
• T Cell Mediated Immunopathology
• Transplantation and Tolerance
• Tumor Micromilieu and Immune Escape
• Veterinary Immunology
More information, online abstract submission, and registration on the website: http://www.immunology-conference.de >>
|
|
|
|
| |
| Magyar Hypertonia Társaság |
|
| 19th Scientific Meeting of the ESH |
| Rendezvény kezdete: 2009.06.12. | Rendezvény vége: 2009.06.16. |
| Helyszín: Italy, Milan, via Gattamelata 2, Milan Convention Centre |
| A rendezvény Web oldala: http://www.eshmilan.org/ |
The scientific programme will continue the tradition of the many ESH meetings which have been held in the past. That is, a large portion of the programme will be devoted to oral and poster presentations which will be selected from the abstracts submitted by the participants, based on the assessment of several expert reviewers per abstract.
The programme will also include:
1) State-of-the-Art Lectures, Debates and Round Tables to complement presentations of original research with views of topics of basic and clinical interest from worldwide authorities in hypertension
2) Satellite Symposia organized by Drug Industry, which will be held in the days before, after and during (evening) the main meeting, allow more specific information on new treatments of hypertension and related cardiovascular diseases to be presented and discussed
3) Breakfast Workshops and scientific sessions organized by the Working Groups of ESH and presentations, in separate sessions, of the research activities of Young European investigators and
4) Teaching Sessions focused on aspects of more practical interest and on clinical cases aimed more specifically at physicians interested in becoming European Hypertension Specialists. Several How-to Sessions aimed at presenting and discussing practical aspects of methods to be used in the initial and subsequent management of hypertension and cardiovascular risk will also be included in the programme, using a format that will allow a limited number of attendees to interact with the expert. |
|
|
|
| |
| Magyar Hypertonia Társaság |
|
| 19th European Meeting on Hypertension |
| Rendezvény kezdete: 2009.06.12. | Rendezvény vége: 2009.06.16. |
| Munkahely neve: AIM Group - AIM Congress |
| Címe: Via Flaminia 1068, 00189 Rome (Italy) |
| Tel: +39 (06) 330531 |
| Fax: +39 (06) 33053249 |
| E-mail: esh2009@aimgroup.it |
| Helyszín: Italy, Milan, via Gattamelata 2., Milan Convention Centre |
| A rendezvény Web oldala: http://www.esh2009.com/ |
Like previous meetings, there is a high quality scientific program related to research in Basic and Clinic areas in Hypertension, State-of-the-Art Lectures, Satellite Symposia, Breakfast Workshops, Working Groups sessions and credits for qualifying as Hypertension Specialists of the European Society of Hypertension.
Hypertension has become the number one cause of death in the world according to a WHO supported investigation. Despite the many scientific advances of the past few decades, much work remains to be done. Although we all do our best to reduce coronary heart disease, stroke, heart failure and cardiovascular complications, diabetes and obesity continue to increase worldwide. Primary and secondary prevention of cardiovascular diseases require a global approach of the cardiovascular risk, and an in-depth understanding of the mechanisms of hypertension. |
|
|
|
